
lifescore Edge
Health
Sleep, recovery, emerging treatments and the evidence behind health claims.

How do you check whether a cited clinical trial exists?
A commercial page cited three KPV trials with 184 participants. The named journal has one KPV paper, on mice, and three registers we searched list no study.
Read article
Do GLP-1 drugs cause disproportionate muscle loss?
Human studies show real lean-mass loss as fat falls more, but direct muscle and function evidence is too thin to prove disproportionate wasting.
Read article
Does oral semaglutide match injectable semaglutide for weight loss?
The approved 25 mg tablet and 2.4 mg weekly injection produced close weight loss in separate trials, but no head-to-head proves equivalence.
Read article
What does human evidence show about retatrutide?
Randomized trials show large weight and glucose reductions, but most Phase 3 obesity results lack full publication and no retatrutide product is approved.
Read article
Do compounded GLP-1 drugs have the same human evidence?
None of the three studies giving people compounded GLP-1 drugs tested equivalence; the one comparison found slightly less weight loss than the approved drug.
Read article
Which claims for seven FDA-reviewed peptides were tested in people?
Four were given to people. None had the same peptide, delivery method, group and claimed result repeated by an independent team.
Read article
Does Emideltide or DSIP improve sleep?
Small IV studies found no established insomnia benefit and none tested subcutaneous use; in 2026, PCAC's nonbinding 503A vote was 6–7–1 against both forms.
Read article
Are Epitalon's sleep and longevity claims backed by human evidence?
A small human study measured a melatonin metabolite, not sleep; longevity claims come from cells or animals, and a 2026 panel vote was not approval.
Read article
Does KPV have human evidence?
FDA found no human KPV trial, pharmacokinetic study, case report or documented exposure; cell, skin and animal studies cannot establish efficacy or safety.
Read article
Does MOTS-c have human metabolic evidence?
Studies track natural MOTS-c during exercise, but FDA found no human administration data; a 120-person Phase 2a trial is recruiting without results.
Read article
Is BPC-157 supported by human evidence?
FDA found two abstract-only trials and three uncontrolled reports with at most 17 people; none proves efficacy, and a 120-person trial is recruiting.
Read article
What did the 2026 FDA peptide hearing actually change?
An advisory committee backed 503A listing for six of seven peptides in free-base and acetate forms; no drug was approved and FDA action is pending.
Read article
What does human evidence show about Semax?
Semax has human studies, but no replicated, well-controlled trial shows better cognition in healthy adults, and FDA found no human pharmacokinetic study.
Read article
What separates TB-500 from thymosin beta-4?
TB-500 is a seven-amino-acid fragment, not 43-amino-acid thymosin beta-4; FDA found no human administration evidence, so results do not transfer.
Read article
Can two short nights make you look less attractive?
A controlled sleep-restriction study found small changes in how strangers rated attractiveness, health, sleepiness and willingness to socialize.
Read articleEdge delivery
Get new Edge articles in your inbox.
Evidence-led insights, delivered when published.